There are 3397 resources available
Pro
Presenter: Noel Clarke
Session: PARP inhibitors for castration-resistant prostate cancer combined with an AR pathway inhibitor: One approach for all
Resources:
Slides
Webcast
Contra
Presenter: Joaquin Mateo
Session: PARP inhibitors for castration-resistant prostate cancer combined with an AR pathway inhibitor: One approach for all
Resources:
Slides
Webcast
First voting
Presenter: Elena Castro
Session: PARP inhibitors for castration-resistant prostate cancer combined with an AR pathway inhibitor: One approach for all
Resources:
Slides
Webcast
Perspective from the Chair
Presenter: Elena Castro
Session: PARP inhibitors for castration-resistant prostate cancer combined with an AR pathway inhibitor: One approach for all
Resources:
Slides
Webcast
Second voting
Presenter: Elena Castro
Session: PARP inhibitors for castration-resistant prostate cancer combined with an AR pathway inhibitor: One approach for all
Resources:
Slides
Webcast
CN37 - Perceptions and attitudes of healthcare providers towards discussing sexuality and sexual problems in cancer patients (from LGBTQ+ backgrounds)
Presenter: Cato Beyts
Session: ECL/EONS collaborative session – Let’s break the taboo around cancer and sexuality: Improving communication and care
Resources:
Abstract
Patients at the centre of the new digital solutions: HealthDay and personalised care
Presenter: Tanja Spanic
Session: How does digitalisation help personalised care throughout the patient journey?
Resources:
Slides
Webcast
822O - Activation of γ9δ2 T cells by ICT01 as a novel immunotherapeutic approach for relapsed/refractory hematologic cancers (EVICTION trial)
Presenter: Sylvain Garciaz
Session: Proffered paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
LBA6 - EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)
Presenter: Thomas Powles
Session: Presidential 2
Resources:
Abstract
Slides
Webcast
2211MO - Uncovering the mechanisms of persistent disease in RET-altered thyroid cancers: Insights from patient-derived xenograft models treated with selective RET inhibitors
Presenter: Alejandro Garcia Alvarez
Session: Mini oral session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast